期刊文献+

Fluorescent silicon nanoparticles-based nanotheranostic agents for rapid diagnosis and treatment of bacteria-induced keratitis 被引量:3

原文传递
导出
摘要 Recommended as a medical emergency,infectious keratitis with an acute and rapid disease progression can lead to serious damage of vision and even blindness.Herein,we present a kind of theranostic agents,which are made of vancomycin(Van)-modified fluorescent silicon nanoparticles(SiNPs-Van),enabling rapid and non-invasive diagnosis and treatment of Gram-positive bacteria-induced keratitis in a simultaneous manner.Typically,the resultant SiNPs-Van nanoagents have an ability of imaging bacteria in a short time both in vitro(5 min)and in vivo(10 min),making them an efficacious diagnostic agent for the detection of bacterial keratitis.In addition,the SiNPs-Van feature distinct antimicrobial activity,with superior activity of 92.5%at a concentration of 0.5 ng/mL against Staphylococcus aureus(S.aureus);comparatively,the antimicrobial rate of free vancomycin is 23.3%at the same concentration.We further explore the SiNPs-Van agents as eye drops for therapy of S.aureus-induced bacterial keratitis on rat model.Represented by slit-lamp scores,the keratitis severity of SiNPs-Van-treated corneas is 3.4,which is 59.6%and 77.3%slighter than vancomycin-(8.2 score)and PBS-treated corneas(15.0 score),respectively.The infected corneas recover to normal(1 score)after 7-d of SiNPs-Van treatment.Above results suggest that the SiNPs-Van could serve as a new kind of high-quality nanotheranostic agents,especially suitable for simultaneous diagnosis and therapy of Gram-positive bacteria keratitis.
出处 《Nano Research》 SCIE EI CAS CSCD 2021年第1期52-58,共7页 纳米研究(英文版)
基金 the National Natural Science Foundation of China(Nos.21825402,21575096,31400860,and 21605109) Natural Science Foundation of Jiangsu Province of China(Nos.BK20170061,BK20191417) the Program for Jiangsu Specially-Appointed Professors to Prof.Yao He,a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD) 111 Project as well as Collaborative Innovation Center of Suzhou Nano Science and Technology(NANO-CIC).
  • 相关文献

参考文献5

二级参考文献43

  • 1Park, K.; Lee, S.; Kang, E.; Kim, K.; Choi, K.; Kwon, I. C. New generation of multifunctionaL nanoparticles for cancer imaging and therapy. Adv. Funct. Mater. 2009, 19, 1553-1566. 被引量:1
  • 2Bardhan, R.; Lal, S.; Joshi, A.; Halas, N. J. Theranostic nanoshells: From probe design to imaging and treatment of cancer. Acc. Chem. Res. 2011, 44, 936-946. 被引量:1
  • 3Fu, A. H.; Wilson, R. J.; Smith, B. R.; MuUenix, J.; Earhart, C.; Akin, D.; Guccione, S.; Wang, S. X.; Gambhir, S. S. Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects. ACS Nano 2012, 6, 6862-6869. 被引量:1
  • 4Yu, J.; Yang, C.; Li, J.; Ding, Y. C.; Zhang, L.; Yousaf, M. Z.; Lin, J.; Pang, R.; Wei, L. B.; Xu, L. L. et al. Multifunetional FesC2 nanoparticles: A targeted theranostic platform for magnetic resonance imaging and photoacoustic tomography-guided photothermal therapy. Adv. Mater. 2014, 26, 4114-120. 被引量:1
  • 5Tang, W.; Zhen, Z. P.; Yang, C.; Wang, L. N.; Cowger, T.; Chen, H. M.; Todd, T.; Hekmatyar, K.; Zhao, Q.; Hou, Y. L et al. FesC2 nanoparticles with high MRI contrast enhancement for tumor imaging. Small 2014, 10, 1245 1249. 被引量:1
  • 6Bertrand, N.; Wu, J.; Xu, X. Y.; Kamaly, N.; Farokhzad, O. C. Cancer nanotechnology: The impact of passive and active targeting in the era of modem cancer biology. Adv. Drug Deliv, Rev. 2014, 66, 2-25. 被引量:1
  • 7Banerjee, D.; Harfouche, R.; Sengupta, S. Nanotechnology- mediated targeting of tumor angiogenesis. Vascular Cell 2011, 3, 3-13. 被引量:1
  • 8Montet, X.; Montet-Abou, K.; Reynolds, F.; Weissleder, R.; Josephson, L. Nanoparticle imaging of integrins on tumor cells. Neoplasia 2006, 8, 214-222. 被引量:1
  • 9Ye, Y. P.; Chen, X. Y. Integrin targeting for tumor optical imaging. Theranostics 2011, 1,102-126. 被引量:1
  • 10Danhier, F.; Le Breton, A.; Pr6at, V. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol. Pharm. 2012, 9, 2961-2973. 被引量:1

共引文献9

同被引文献21

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部